Doctor-led medical care · Ubi, Singapore 6844 1528 WhatsApp
Hormones

Parathyroid Hormone (PTH) and Obesity

Parathyroid hormone rises with body fat, so people with obesity commonly have secondary hyperparathyroidism even with normal calcium; after weight-loss surgery the prevalence climbs from about a fifth before surgery to nearly two thirds at five years.

Plain English

Patient-Friendly Explanation

The parathyroid glands are four small glands in the neck that control calcium in the blood. They do this by releasing parathyroid hormone, which pulls calcium out of bone, increases its absorption from the gut through vitamin D, and reduces how much is passed in urine. When calcium or vitamin D runs low, parathyroid hormone rises to compensate, and the resulting state is called secondary hyperparathyroidism. Body fat is now known to push parathyroid hormone upward as well. In a large surgical series, one in five patients with obesity had a raised parathyroid hormone before any operation, with normal calcium and often low vitamin D. That prevalence rose to about one in three a year after surgery and to nearly two in three at five years, the figures differing by procedure type. Part of the reason is that vitamin D dissolves in fat, so a person with more fat tissue needs and stores more of it, and part is simply that parathyroid hormone levels track body weight and fat mass even when vitamin D is taken into account. Leptin, a hormone made by fat tissue, also appears to stimulate the parathyroid glands directly. The practical importance is bone and mineral health. Persistently raised parathyroid hormone increases bone turnover and, over years, contributes to bone loss, which matters because bone density already falls after weight-loss surgery and after rapid weight loss by any method. It also explains some fatigue, muscle aches and kidney stone risk, although calcium levels stay normal in the secondary form. The good news is that the problem is straightforward to detect and to treat: a blood test for calcium, vitamin D and parathyroid hormone shows what is happening, and correcting low vitamin D with supplementation, ensuring adequate calcium intake and reviewing the need for the checks at least once a year after weight-loss surgery are the standard measures. Weight loss itself lowers parathyroid hormone, which is one more reason the operation helps metabolic health.

Medical

Clinical Definition

Obesity is associated with higher circulating parathyroid hormone (PTH) concentrations, at least partly independent of 25-hydroxyvitamin D and renal function. In a series of 2,412 bariatric patients, secondary hyperparathyroidism (PTH above 69 pg/mL with normal calcium) was present in 21.0% before surgery and rose to 35.4% at one year and 63.3% at five years; at five years the prevalence was largest after single-anastomosis gastric bypass (73.6%), followed by Roux-en-Y gastric bypass (56.6%), sleeve gastrectomy (41.7%) and adjustable gastric banding (38.5%). Pre-operative PTH correlated positively with body mass index (r=0.151, p<0.001) and negatively with 25-hydroxyvitamin D (r=-0.447), and vitamin D was the only independent baseline predictor of secondary hyperparathyroidism. Cross-sectional analyses report each 10% higher body fat associated with about 0.4 pmol/L higher PTH and each 1 kg/m2 higher body mass index with about 1.3 nmol/L lower 25-hydroxyvitamin D. In a prospective study of severely obese patients before and after sleeve gastrectomy, PTH fell substantially with fat-mass reduction independently of changes in 25-hydroxyvitamin D, calcium, phosphate and renal function, and the fall correlated with reductions in total and truncal fat mass and in leptin. The mechanisms proposed are sequestration and accelerated inactivation of vitamin D in adipose tissue, reduced sun exposure and dietary calcium intake, a direct stimulatory effect of leptin on the parathyroid glands, reduced renal 1-alpha-hydroxylase activity, and calcium loss from a higher filtered load. Consequences include increased bone turnover and accelerated bone loss, which compounds the skeletal effects of bariatric surgery and of rapid weight loss, and an association with insulin resistance, arterial calcification and metabolic syndrome components, although much of the latter appears mediated by adiposity itself. Assessment is by simultaneous measurement of calcium, 25-hydroxyvitamin D, PTH and renal function, and alkaline phosphatase where bone turnover is a concern; a raised PTH with normal or low calcium indicates the secondary form, while a raised calcium points to primary hyperparathyroidism and needs separate investigation. Management is correction of vitamin D deficiency, adequate calcium intake, and annual monitoring after malabsorptive surgery, with weight loss itself reducing PTH in proportion to fat-mass reduction.

Key Insight

Why It Matters

This term is practical rather than theoretical. It explains why patients with obesity, and especially those who have had weight-loss surgery, need calcium, vitamin D and parathyroid hormone checked rather than vitamin D alone, and why the check needs to be repeated yearly because the prevalence keeps rising over time. It also reassures patients whose results come back mildly abnormal: a raised parathyroid hormone with normal calcium is usually a response to low vitamin D and improves with the right supplementation, whereas a raised calcium needs a different investigation. Attending to bone and mineral health alongside weight loss protects the skeleton while the weight comes down.

Sources

Reviewed against standard medical references.

Medically reviewed by

Dr Joseph Wang

Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).

Last reviewed: October 2026

This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.

WhatsApp